Results for the year ended 31 December 2022 Significant milestones reached, well capitalised and positioned for future growth LONDON, UK / ACCESSWIRE / March
First time AI has been used to identify disease targets in RSVLONDON, UK / ACCESSWIRE / November 8, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious